Medicare Enrolled

Dr. Robert Laningham, MD

Family Medicine · Conroe, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4015 INTERSTATE 45 N STE 220, Conroe, TX 77304
9364411122
In practice since 2006 (19 years)
NPI: 1700973682 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Laningham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Laningham? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Laningham

Dr. Robert Laningham is a family medicine in Conroe, TX, with 19 years in practice. Based on federal Medicare data, Dr. Laningham performed 80,882 Medicare services across 11,235 unique beneficiaries.

Between the years covered by Open Payments, Dr. Laningham received a total of $2,645 from 37 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Laningham is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 0% volume in TX$ $2,645 industry payments

Medicare Practice Summary

Medicare Utilization ↗
80,882
Medicare services
Top 0% in TX for family medicine
11,235
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,257 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Testosterone injection61,501$0$0
Office visit, established patient (30-39 min)2,354$81$254
Dexamethasone injection (steroid)2,131$0$6
Blood draw (venipuncture)1,330$8$20
Complete blood count (CBC) with differential1,158$8$27
Comprehensive metabolic blood panel1,104$10$36
Thyroid stimulating hormone (TSH) test983$16$58
Thyroid hormone, t3 measurement, free972$17$58
Free thyroxine (T4) test958$9$31
Hemoglobin A1c test (diabetes monitoring)922$10$33
Lipid panel (cholesterol and triglycerides)909$13$46
Steroid injection (triamcinolone)859$1$4
Drug injection, under skin or into muscle825$9$60
Vitamin D level test776$29$93
Office visit, established patient, complex (40-54 min)554$120$340
Annual depression screening351$18$43
Annual wellness visit, follow-up350$123$266
Annual alcohol misuse screening, 5 to 15 minutes337$18$43
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes219$25$61
Injection, ketorolac tromethamine, per 15 mg216$0$12
Urinalysis, manual211$3$10
Ceftriaxone antibiotic injection210$0$13
Prostate cancer screening; prostate specific antigen test (psa)202$19$63
Administration and interpretation of patient-focused health risk assessment186$1$35
Testosterone (hormone) level, total177$25$89
Office visit, established patient (20-29 min)138$57$173
PSA test (prostate cancer screening)132$18$63
Face-to-face behavioral counseling for obesity, 15 minutes117$24$61
Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected107$140$200
Transitional care management services for problem of high complexity99$206$549
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg81$1$10
Electrocardiogram (EKG), 12-lead65$9$43
New patient office visit (45-59 min)63$88$392
Transitional care management services for problem of at least moderate complexity46$153$388
Destruction of precancerous skin growths, 2-1444$5$37
Removal of impacted ear wax43$33$125
New patient office visit, complex (60-74 min)33$138$486
Destruction of precancerous skin growth, 132$35$194
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique32$34$88
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional20$17$48
Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment20$151$390
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and15$40$126
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,645
Total received (2018-2024)
Avg $378/year across 7 years
Top 22% in TX for family medicine
37
Companies
158
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,626 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$462
2023
$261
2022
$308
2021
$553
2020
$262
2019
$360
2018
$438

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$283
Dexcom, Inc.
$192
AbbVie Inc.
$182
ABBVIE INC.
$170
Amgen Inc.
$157
Novo Nordisk Inc
$150
Takeda Pharmaceuticals U.S.A., Inc.
$150
AstraZeneca Pharmaceuticals LP
$129
Allergan, Inc.
$119
Janssen Pharmaceuticals, Inc
$113
GlaxoSmithKline, LLC.
$106
Lilly USA, LLC
$105
PFIZER INC.
$97
Astellas Pharma US Inc
$92
Stemline Therapeutics Inc.
$71
Medtronic, Inc.
$48
SANOFI-AVENTIS U.S. LLC
$41
Medtronic Vascular, Inc.
$39
Coloplast Corp
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$34
DEXCOM, INC.
$34
Allergan Inc.
$31
Indivior Inc.
$25
Synergy Pharmaceuticals Inc
$25
Inspire Medical Systems, Inc.
$24
Medline Industries, Inc.
$22
Corcept Therapeutics
$21
Orexo US, Inc.
$20
Kowa Pharmaceuticals America, Inc.
$18
Novartis Pharmaceuticals Corporation
$16
Corium, LLC
$14
Biohaven Pharmaceuticals, Inc.
$14
Merck Sharp & Dohme Corporation
$14
ARBOR PHARMACEUTICALS, INC.
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Eisai Inc.
$12
Amarin Pharma Inc.
$11
Top 3 companies account for 24.9% of total payments
Associated products mentioned in payments ›
ALTIS · AZSTARYS · Aimovig · Axium INS DRG IPG · BELSOMRA · BOTOX COSMETIC · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COREVALVE EVOLUT R · ClosureFast · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · Horizant · INSPIRE · INVOKANA · JARDIANCE · Korlym · Livalo · NURTEC ODT · Orserdu · Otezla · Ozempic · PREVNAR - 13 · PROCLAIM · Proclaim Family of SCS IPGs · QULIPTA · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · SUBLOCADE · SYMBICORT · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Trintellix · Trulance · UBRELVY · VANTA ADAPTIVESTIM · VENASEAL · VIIBRYD · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3 per 100 Medicare services performed
Looking for a family medicine in Conroe?
Compare family medicines in the Conroe area by procedure volume, costs, and industry payment transparency.
Browse family medicines nearby

Geographic Context

Family Medicines within 10 mi
445
Per 100K population
68.0
County median income
$97,266
Nearest hospital
HCA HOUSTON HEALTHCARE CONROE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Laningham is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Laningham experienced with testosterone injection?
Based on Medicare claims data, Dr. Laningham performed 61,501 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Laningham receive payments from pharmaceutical companies?
Yes. Dr. Laningham received a total of $2,645 from 37 companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Laningham's costs compare to other family medicines in Conroe?
Dr. Laningham's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Laningham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →